[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"limb-fusion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:limb-fusion":23},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":5},"100486728","application-of-antiosteoporosis-therapy-in-osteolysis-100486728",false,"NCT05617846","Application of Antiosteoporosis Therapy in Osteolysis","Efficacy and Safety of Antiosteoporosis Therapy in Patients After Bone Tumor Resection: a Multicenter, Real-world Prospective Cohort Observational Study","Inclusion Criteria:\n\n1. No age restriction, male or female.\n2. A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.\n3. Received excision of bone tumor in research institution.\n\nExclusion Criteria:\n\nNot applicable.","ALL",{"count":18,"type":19},100,"ESTIMATED","OBSERVATIONAL","To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.",[23,24],"Limb; Fusion","Complication","NOT_YET_RECRUITING","2024-01-16",{"date":28,"type":29},"2024-01-18","ACTUAL",{"date":31,"type":19},"2024-12-28",{"date":33,"type":19},"2032-11-30",{"name":35,"class":36},"Henan Cancer Hospital","OTHER_GOV"]